Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2024 (FY24)
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: to be announced
External Deadline: to be announced
Description
The FY24 Defense Appropriations Act is anticipated to provide funding for the Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command (USAMRDC).
The PRCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY24 funding opportunities. This pre-announcement should not be construed as an obligation by the government. The FY24 PRCRP funding opportunity announcements for the following award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the announcements are released.
Congressionally Directed Topic Areas: The FY24 PRCRP appropriation will provide funds for research into cancers not addressed in the other CDMRP cancer programs (https://cdmrp.health.mil/researchprograms). To be considered for funding, applications for the FY24 PRCRP must address at least one of the FY24 PRCRP Topic Areas as directed by Congress. At the time of this pre-announcement, the final FY24 PRCRP Topic Areas are not known. To reference past PRCRP Topic Areas, please reference https://cdmrp.health.mil/prcrp/topicareas/topicareas. When the FY24 Defense Appropriations Act has been signed into law, the PRCRP will update this announcement with the FY24 Topic Areas.
The Peer Reviewed Cancer Research Program (PRCRP) released a pre-announcement for the following funding opportunities:
- Advancing Clinical Care Through Clinical Trials Award
- Career Development Award – Scholar Option
- Convergent Science Cancer Consortium Award
- Idea Award
- Impact Award
- Patient Well-Being and Survivorship Award
- Virtual Cancer Center Director Award
See here for more information.